We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vancomycin Serum Concentrations in Pediatric Oncology Patients Under Intensive Care

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2012 by GLAUCIA TORIBIO FINOTI SEIXAS, Grupo de Apoio ao Adolescente e a Crianca com Cancer.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01304459
First Posted: February 25, 2011
Last Update Posted: March 23, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
GLAUCIA TORIBIO FINOTI SEIXAS, Grupo de Apoio ao Adolescente e a Crianca com Cancer
  Purpose
Observational protocol to analyse routine vancomycin serum levels of patients under intensive care and to obtain percentage of patients that achieve therapeutic values.

Condition
Infection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Vancomycin Serum Concentrations in Pediatric Oncology Patients Under Intensive Care

Resource links provided by NLM:


Further study details as provided by GLAUCIA TORIBIO FINOTI SEIXAS, Grupo de Apoio ao Adolescente e a Crianca com Cancer:

Estimated Enrollment: 50
Study Start Date: January 2011
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pediatric oncology patients on intensive care unit for treatment of infections.
Criteria

Inclusion Criteria:

  • Hospitalized pediatric oncology patients
  • Patients under vancomycin treatment
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01304459


Contacts
Contact: Glaucia T Finoti, MD 55-11-5080-8575 glaucia.finoti@gmail.com

Locations
Brazil
Grupo de Apoio ao Adolescente e à Criança com Câncer Recruiting
Sao Paulo, Brazil, 04023-062
Sponsors and Collaborators
Grupo de Apoio ao Adolescente e a Crianca com Cancer
  More Information

Responsible Party: GLAUCIA TORIBIO FINOTI SEIXAS, MD, Grupo de Apoio ao Adolescente e a Crianca com Cancer
ClinicalTrials.gov Identifier: NCT01304459     History of Changes
Other Study ID Numbers: UTI/IOP 01/11
1913/10 ( Other Identifier: CEP UNIFESP )
First Submitted: February 24, 2011
First Posted: February 25, 2011
Last Update Posted: March 23, 2012
Last Verified: March 2012

Additional relevant MeSH terms:
Vancomycin
Anti-Bacterial Agents
Anti-Infective Agents